Fortuitously, there is already a large, multicenter trial in place using VNS to reduce cytokines, including IL-6, in patients with rheumatoid arthritis, “The RESET-RA Study” (NCT #04539964) [Peterson et al., 2024]. The gene discussed is IL6; the disease is rheumatoid arthritis.